PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP)

117 filings reported holding PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share as of Q2 2024.
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 40,492,185 shares of 52,942,731 outstanding shares and own 76% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6,475,291 shares), ArrowMark Colorado Holdings LLC (2,804,782 shares), Sio Capital Management, LLC (2,708,408 shares), Euclidean Capital LLC (2,627,643 shares), ALKEON CAPITAL MANAGEMENT LLC (2,345,361 shares), VANGUARD GROUP INC (2,282,090 shares), ACADIAN ASSET MANAGEMENT LLC (2,078,866 shares), CITADEL ADVISORS LLC (1,716,474 shares), BML Capital Management, LLC (1,309,397 shares), and PFM Health Sciences, LP (1,275,462 shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.